Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-caed-2_14-cv-02571/USCOURTS-caed-2_14-cv-02571-1/pdf.json

Nature of Suit Code: 850
Nature of Suit: Securities, Commodities, Exchange
Cause of Action: 15:77 Securities Fraud

---

STIPULATION AND ORDER (1) SETTING TIME FOR FILING OF CONSOLIDATED CLASS ACTION COMPLAINT, (2)

ESTABLISHING BRIEFING SCHEDULE FOR RESPONSIVE MOTION(S) AND (3) CONTINUING REQUIREMENT FOR 

SUBMISSION OF DISCOVERY PLAN

MASTER FILE NO. : 2:14-CV-2571-MCE-KJN 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23

24 

25 

26 

27 

28 

LOWENSTEIN SANDLER LLP 

Michael J. McGaughey (198617) 

390 Lytton Avenue 

Palo Alto, CA 94301 

Telephone: 415-288-4545 

Fax: 415-288-4534 

mmcgaughey@lowenstein.com 

Counsel for Lead Plaintiffs Special Situations 

Fund III QP, L.P. and Special Situations 

Cayman Fund, L.P. 

(Additional Counsel on Signature Page) 

UNITED STATES DISTRICT COURT 

EASTERN DISTRICT OF CALIFORNIA 

SPECIAL SITUATIONS FUND III QP, L.P., 

AND SPECIAL SITUATIONS CAYMAN 

FUND, L.P, Individually and On Behalf of 

All Others Similarly Situated, 

 Plaintiffs, 

vs. 

MARRONE BIO INNOVATIONS, INC., 

PAMELA G. MARRONE, JAMES B. 

BOYD, DONALD J. GLIDEWELL, 

HECTOR ABSI, ELIN MILLER, RANJEET 

BHATIA, PAMELA CONTAG, TIM 

FOGARTY, LAWRENCE HOUGH, 

JOSEPH HUDSON, LES LYMAN, 

RICHARD ROMINGER and SHAUGN 

STANLEY, 

 Defendants. 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

Master File No.: 2:14-cv-2571-MCE-KJN

Chief Judge Morrison C. England, Jr. 

CONSOLIDATED CLASS ACTION 

STIPULATION AND ORDER (1) 

SETTING TIME FOR FILING OF 

CONSOLIDATED CLASS ACTION 

COMPLAINT, (2) ESTABLISHING 

BRIEFING SCHEDULE FOR 

RESPONSIVE MOTION(S) AND (3) 

CONTINUING REQUIREMENT 

FOR SUBMISSION OF 

DISCOVERY PLAN 

(caption continued on the following page) 

Case 2:14-cv-02571-MCE-KJN Document 27 Filed 04/16/15 Page 1 of 8
 

STIPULATION AND ORDER (1) SETTING TIME FOR FILING OF CONSOLIDATED CLASS ACTION COMPLAINT, (2)

ESTABLISHING BRIEFING SCHEDULE FOR RESPONSIVE MOTION(S) AND (3) CONTINUING REQUIREMENT FOR 

SUBMISSION OF DISCOVERY PLAN

MASTER FILE NO. : 2:14-CV-2571-MCE-KJN 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23

24 

25 

26 

27 

28 

 

JOANN N. MARTINELLI, Individually and 

On Behalf of All Others Similarly Situated, 

Plaintiff, 

vs. 

MARRONE BIO INNOVATIONS, INC., 

PAMELA G. MARRONE, DONALD J. 

GLIDEWELL, and JAMES B. BOYD, 

 Defendants. 

) 

) 

) 

) 

)

) 

) 

) 

) 

) 

) 

) 

) 

PAUL SAUSMAN, Individually and On 

Behalf of All Others Similarly Situated, 

Plaintiff, 

vs. 

MARRONE BIO INNOVATIONS, INC., 

PAMELA G. MARRONE, DONALD J. 

GLIDEWELL, and JAMES B. BOYD, 

 Defendants. 

) 

) 

) 

) 

) 

) 

)

) 

) 

) 

) 

) 

) 

(caption continued on the following page) 

Case 2:14-cv-02571-MCE-KJN Document 27 Filed 04/16/15 Page 2 of 8
 

STIPULATION AND ORDER (1) SETTING TIME FOR FILING OF CONSOLIDATED CLASS ACTION COMPLAINT, (2)

ESTABLISHING BRIEFING SCHEDULE FOR RESPONSIVE MOTION(S) AND (3) CONTINUING REQUIREMENT FOR 

SUBMISSION OF DISCOVERY PLAN

MASTER FILE NO. : 2:14-CV-2571-MCE-KJN 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23

24 

25 

26 

27 

28 

SUSCHIA CHEN, Individually and On 

Behalf of All Others Similarly Situated, 

Plaintiff, 

vs. 

MARRONE BIO INNOVATIONS, INC., 

PAMELA G. MARRONE, DONALD J. 

GLIDEWELL, and JAMES B. BOYD, 

 Defendants. 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

KENT OLDHAM, Individually and On 

Behalf of All Others Similarly Situated, 

Plaintiff, 

vs. 

MARRONE BIO INNOVATIONS, INC., 

JAMES B. BOYD, DONALD J. 

GLIDEWELL, PAMELA G. MARRONE, 

RANJEET BHATIA, TIM FOGARTY, 

LAWRENCE HOUGH, JOSEPH HUDSON, 

RICHARD ROMINGER, SEAN 

SCHICKEDANZ, SHAUGN STANLEY, 

PIPER JAFFRAY & CO., STIFEL, 

NICOLAUS & COMPANY, 

INCORPORATED, ROTH CAPITAL 

PARTNERS, LLC, and JEFFERIES LLC,

 Defendants. 

) 

) 

) 

) 

) 

) 

) 

)

) 

) 

) 

) 

) 

) 

) 

) 

) 

)

) 

) 

) 

 Lead Plaintiffs Special Situations Fund III QP, L.P. and Special Situations Cayman 

Fund, L.P. (“Lead Plaintiffs”) and Defendants Marrone Bio Innovations, Inc. (“MBII”), Pamela 

G. Marrone, James B. Boyd, Donald J. Glidewell, Hector Absi, Elin Miller, Ranjeet Bhatia, 

Pamela Contag, Tim Fogarty, Lawrence Hough, Joseph Hudson, Les Lyman, Richard 

Case 2:14-cv-02571-MCE-KJN Document 27 Filed 04/16/15 Page 3 of 8
 

STIPULATION AND ORDER (1) SETTING TIME FOR FILING OF CONSOLIDATED CLASS ACTION COMPLAINT, (2)

ESTABLISHING BRIEFING SCHEDULE FOR RESPONSIVE MOTION(S) AND (3) CONTINUING REQUIREMENT FOR 

SUBMISSION OF DISCOVERY PLAN

MASTER FILE NO. : 2:14-CV-2571-MCE-KJN 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23

24 

25 

26 

27 

28 

Rominger, Shaugn Stanley, and Sean Schickedanz (collectively, “Defendants”), by and through 

their respective counsel hereby recite and stipulate, subject to the approval of the Court, the 

following as concerns (1) the filing of a consolidated class action complaint (“Consolidated 

Complaint”), (2) the briefing schedule for any responsive motions and (3) continuing the date 

by which the parties must file a Fed. R. Civ. P. 26(f) discovery plan. 

RECITALS 

 WHEREAS Lead Plaintiffs filed a class action complaint on November 3, 2014 [Docket 

No. 1], alleging that Defendants engaged in conduct that violates the federal securities laws, 

specifically Sections 11 and 15 of the Securities Act of 1933 and Sections 10(b) and 20(a) of the 

Securities Exchange Act of 1934; 

 WHEREAS certain claims in this action are subject to the Private Securities Litigation 

Reform Act of 1995 (the “PSLRA”); 

WHEREAS counsel for Defendants accepted service of the initial complaint on 

Defendants’ behalf, and the parties entered into a stipulation continuing the date by which 

Defendants must answer or otherwise respond to the complaint until after the Court issued an 

order pursuant to the PSLRA appointing lead plaintiff(s) and lead counsel [Docket No. 13]; 

WHEREAS the parties further stipulated that counsel for Defendants would meet and 

confer with the Court-appointed lead counsel within twenty (20) days following the Court’s 

order appointing lead plaintiff(s) and lead counsel, to determine (i) whether the lead plaintiff(s) 

will file a Consolidated Complaint, (ii) establish a common response date for all defendants, 

including a briefing schedule on anticipated motions to dismiss, and (iii) establish a date by 

which to provide the Court with a Joint Status Report; 

WHEREAS, by Order dated February 13, 2015 [Docket No. 18], this Court consolidated 

the actions denominated as Martinelli v. Marrone Bio Innovations, Inc., No. 2:14-cv-2055-

MCE-KJN, Sausman v. Marrone Bio Innovations, Inc., No. 2:14-cv-2072-MCE-KJN, Chen v. 

Marrone Bio Innovations, Inc., 2:14-cv-2105-MCE-KJN, Oldham v. Marrone Bio Innovations, 

Inc., 2:14-cv-2130-MCE-KJN, and Special Situations Fund III QP, L.P. v. Marrone Bio 

Case 2:14-cv-02571-MCE-KJN Document 27 Filed 04/16/15 Page 4 of 8
 

STIPULATION AND ORDER (1) SETTING TIME FOR FILING OF CONSOLIDATED CLASS ACTION COMPLAINT, (2)

ESTABLISHING BRIEFING SCHEDULE FOR RESPONSIVE MOTION(S) AND (3) CONTINUING REQUIREMENT FOR 

SUBMISSION OF DISCOVERY PLAN

MASTER FILE NO. : 2:14-CV-2571-MCE-KJN 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23

24 

25 

26 

27 

28 

Innovations, Inc., No. 2:14-cv-2571-MCE-KJN, designating No. 2:14-cv-2571 as the Master 

File and administratively closing all other of the consolidated cases; 

 WHEREAS, by that same Order, the Court appointed Special Situations Fund III QP, 

L.P. and Special Situations Cayman Fund, L.P. as Lead Plaintiffs, and Lowenstein Sandler LLP 

as Lead Counsel; 

 WHEREAS the Court issued an Order Requiring Joint Status Report [Docket No. 22], 

which directs the parties to submit a Joint Status Report that includes, among other things, a 

discovery plan pursuant to Fed. R. Civ. Proc. 26(f); 

 WHEREAS, on February 4, 2015, MBII announced that its Audit Committee 

investigation of certain revenue recognition issues is substantially complete, and that MBII’s 

management is evaluating the necessity, nature and scope of any restatements to certain of its 

financial statements previously filed with the Securities and Exchange Commission (“SEC”) 

(the “Financial Statement Review”); 

 WHEREAS the Financial Statement Review may significantly impact the content of the 

allegations in the Consolidated Complaint; 

 WHEREAS, on January 27, 2015, MBII received an extension from The NASDAQ 

Stock Market LLC (“NASDAQ”) granting it until May 13, 2015 to file any delinquent periodic 

financial reports and regain compliance with NASDAQ listing requirements; 

 WHEREAS Lead Plaintiffs intend to file a Consolidated Complaint, and Defendants 

have indicated that they intend to move to dismiss the Consolidated Complaint pursuant to Fed. 

R. Civ. Proc. 12; 

 WHEREAS, pursuant to the PSLRA, 15 U.S.C. § 78u-4(b)(3)(B), all discovery in this 

consolidated class action will be automatically stayed by operation of law should the 

Defendants move to dismiss the Consolidated Complaint; 

 WHEREAS, although Lead Plaintiffs may properly file the Consolidated Complaint at 

any time, undersigned counsel agree that the interests of justice would be best served by an 

order directing Lead Plaintiffs to file the Consolidated Complaint after MBII announces the 

Case 2:14-cv-02571-MCE-KJN Document 27 Filed 04/16/15 Page 5 of 8
 

STIPULATION AND ORDER (1) SETTING TIME FOR FILING OF CONSOLIDATED CLASS ACTION COMPLAINT, (2)

ESTABLISHING BRIEFING SCHEDULE FOR RESPONSIVE MOTION(S) AND (3) CONTINUING REQUIREMENT FOR 

SUBMISSION OF DISCOVERY PLAN

MASTER FILE NO. : 2:14-CV-2571-MCE-KJN 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23

24 

25 

26 

27 

28 

results of the Financial Statement Review, so as to avoid the expense and delay that would be 

incurred by further amending the Consolidated Complaint should the Financial Statement 

Review result in any restatement while Defendants’ anticipated motion(s) to dismiss are being 

briefed; 

 WHEREAS the undersigned counsel further agree that the interests of justice and 

judicial economy would be best served by an order continuing the date by which the parties 

must submit a Rule 26(f) discovery plan in this PSLRA case until after the Court has decided all 

motions filed by Defendants in response to the Consolidated Complaint. 

STIPULATION 

 THEREFORE, IT IS HEREBY STIPULATED AND AGREED by Lead Plaintiffs and 

Defendants, through their respective counsel of record, as follows: 

 1. Lead Plaintiffs shall file and serve the Consolidated Complaint no later than 

thirty (30) days after MBII announces the results of the Financial Statement Review. If MBII 

does not announce the results of the Financial Statement Review by May 13, 2015, Lead 

Plaintiffs shall file and serve the Consolidated Complaint no later than June 1, 2015. 

 2. Defendants shall file and serve any responsive pleading(s) or motion(s) to 

dismiss no later than forty-five (45) days after the filing and service of the Consolidated 

Complaint. 

 3. If a motion to dismiss is filed, Lead Plaintiffs shall file and serve their opposition 

brief(s) no later than forty-five (45) days after Defendants file and serve their motion(s) to 

dismiss. 

 4. Defendants shall file and serve their reply(ies) in further support of the motion(s) 

to dismiss no later than twenty-one (21) days after Lead Plaintiffs file and serve their opposition 

brief(s). 

 5. In the event Defendants’ motion(s) to dismiss are denied in whole or in part, 

Lead Plaintiffs and Defendants shall meet and confer within forty-five (45) days of the Court’s 

disposition of Defendants’ motion(s) to dismiss to address the discovery-related topics set forth 

Case 2:14-cv-02571-MCE-KJN Document 27 Filed 04/16/15 Page 6 of 8
 

STIPULATION AND ORDER (1) SETTING TIME FOR FILING OF CONSOLIDATED CLASS ACTION COMPLAINT, (2)

ESTABLISHING BRIEFING SCHEDULE FOR RESPONSIVE MOTION(S) AND (3) CONTINUING REQUIREMENT FOR 

SUBMISSION OF DISCOVERY PLAN

MASTER FILE NO. : 2:14-CV-2571-MCE-KJN 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23

24 

25 

26 

27 

28 

in the Court’s Order Requiring Joint Status Report and will thereafter submit to the Court a Rule 

26(f) discovery plan consistent with that Order. 

DATED: April 7, 2015 LOWENSTEIN SANDLER LLP

 

 By: __/s/ Michael J. McGaughey___________ 

Michael J. McGaughey 

Lowenstein Sandler LLP 

390 Lytton Avenue 

Palo Alto, CA 94301 

Telephone: 415-288-4545

Fax: 415-288-4534 

mmcgaughey@lowenstein.com

Lawrence M. Rolnick (pro hac vice) 

Steven M. Hecht (pro hac vice) 

Thomas E. Redburn, Jr. (pro hac vice) 

Lowenstein Sandler LLP 

1251 Avenue of the Americas 

New York, NY 10020 

 -and65 Livingston Avenue 

Roseland, NJ 07068 

Telephone: 212-262-6700 

Fax: 973-597-2400 

lrolnick@lowenstein.com 

shecht@lowenstein.com 

tredburn@lowenstein.com 

Counsel for Lead Plaintiffs Special 

Situations Fund III QP, L.P. and Special 

Situations Cayman Fund, L.P.

 

 MORRISON & FOERSTER LLP 

By: __/s/ Judson E. Lobdell_______________ 

(as authorized on April 7, 2015) 

 Judson E. Lobdell 

 Jordan Eth 

 Morrison & Foerster LLP 

425 Market Street 

Case 2:14-cv-02571-MCE-KJN Document 27 Filed 04/16/15 Page 7 of 8
 

STIPULATION AND ORDER (1) SETTING TIME FOR FILING OF CONSOLIDATED CLASS ACTION COMPLAINT, (2)

ESTABLISHING BRIEFING SCHEDULE FOR RESPONSIVE MOTION(S) AND (3) CONTINUING REQUIREMENT FOR 

SUBMISSION OF DISCOVERY PLAN

MASTER FILE NO. : 2:14-CV-2571-MCE-KJN 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23

24 

25 

26 

27 

28 

San Francisco, CA 94105 

Telephone: 415-268-7000 

Facsimile: 415-268-7522 

 

Counsel for Defendants Marrone Bio 

Innovations, Inc., Pamela G. Marrone, 

James B. Boyd, Donald J. Glidewell, Elin 

Miller, Ranjeet Bhatia, Pamela Contag, 

Tim Fogarty, Lawrence Hough, Joseph 

Hudson, Les Lyman, Richard Rominger, 

Shaugn Stanley, and Sean Schickedanz 

BROWNSTEIN HYATT FARBER 

SCHRECK LLP 

 By: __/s/ Jonathan C. Sandler_____________ 

(as authorized on April 7, 2015)

 Jonathan C. Sandler 

 2049 Century Park East, Suite 3550 

 Los Angeles, CA 90067 

Telephone: 310-500-4600 

Facsimile: 310-500-4602 

Counsel for Defendant Hector Absi 

ORDER

 Pursuant to the parties’ stipulation, IT IS SO ORDERED. 

Dated: April 13, 2015 

Case 2:14-cv-02571-MCE-KJN Document 27 Filed 04/16/15 Page 8 of 8